Pediatric Early Rehabilitation in Acute Lymphoblastic Leukemia
PEACE
1 other identifier
interventional
10
1 country
1
Brief Summary
The purpose of this study is to determine the feasibility and acceptability of a hybrid in-person and virtual individualized physiotherapy program using the Healthy Eating and Active Living (HEAL-ME) online platform for children diagnosed with acute lymphoblastic leukemia. We would like to know if this type of hybrid program delivery model is feasible, and if children and their parents are willing and able to participate in the program. We will do this by recording how many, and what type of physiotherapy sessions (in-person or virtual) are completed, what resources offered on the platform are accessed, and how many children complete the assessments.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Apr 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 6, 2023
CompletedFirst Posted
Study publicly available on registry
December 14, 2023
CompletedStudy Start
First participant enrolled
April 15, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedFebruary 6, 2026
February 1, 2026
1.7 years
December 6, 2023
February 3, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Retention rate
The number of participants completing the intervention and assessments
Post-intervention: 12 weeks
Secondary Outcomes (5)
Recruitment rate
One year
Adherence to study intervention
Post-intervention: 12 weeks
Adverse events
One year
Acceptability
Post-intervention: 12 weeks
Health-related Quality of Life
Post-intervention: 12 weeks
Study Arms (1)
Intervention
EXPERIMENTALChildren will participate in six PT sessions over the course of 12 weeks and will be provided with the option to choose their preferred mode of the delivery (i.e., 1:1 in-person, 1:1 virtual, group virtual, or a combination of all). The program will be tailored to the child's age, presenting symptoms, and preferred activities. Children and parents/ caregivers will be encouraged to carry out additional tailored PT sessions through their preferred mode of delivery and to access the exercise videos provided in the additional resources section of the HEAL-ME platform.
Interventions
Each physical therapy session will commence with a 5-minute warm-up, with fun activities to mobilize the joints and activate the muscles, using the videos available in the HEAL-ME platform. The warm-up session will be followed by a 20 to 40-min program with tailored activities and games comprising jumping, squatting, skipping, balancing, and jogging. The session will finish with a 5-minute cool down with stretching exercises and a relaxation video from the HEAL-ME platform.
Eligibility Criteria
You may qualify if:
- Children diagnosed with acute lymphoblastic leukemia aged between 4 and 17 years (at time of diagnosis) and their mother, father, or primary carer;
- Undergoing or completed cancer treatment as established by the Children's Oncology Group;
- Access to the internet through a home computer or tablet;
- Patient or caregiver is able to speak and comprehend English; and
- The child is approved by their Oncologist to participate in the program.
You may not qualify if:
- Children with a history of a neurodevelopmental or genetic disorder (i.e., Down syndrome, autism, seizure disorder) prior to the cancer diagnosis; and
- Children with a concurrent condition (illness, disease, psychiatric disorder), as determined by oncologist or physiotherapist, that would compromise study participation or interpretation of study results.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Alberta Health servicescollaborator
- University of Albertalead
Study Sites (1)
University of Alberta
Edmonton, Alberta, T6G2R3, Canada
MeSH Terms
Conditions
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Margaret McNeely, PhD
University of Alberta
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 6, 2023
First Posted
December 14, 2023
Study Start
April 15, 2024
Primary Completion
December 31, 2025
Study Completion
December 31, 2025
Last Updated
February 6, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, ICF, CSR
- Time Frame
- when the study has been completed and after the findings are published
- Access Criteria
- Open access
Data will be deposited on the University of Alberta's dataverse